These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35616754)

  • 1. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
    Zhu T; Pan Z; Zhang N
    Clin Rheumatol; 2022 Sep; 41(9):2791-2802. PubMed ID: 35616754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
    Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
    Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
    Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
    Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
    Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
    Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
    Loureiro-Amigo J; Franco-Jarava C; Perurena-Prieto J; Palacio C; Martínez-Valle F; Soláns-Laqué R
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
    Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
    Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
    Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of CD8
    Li H; Zhou Y; Wang P; Wang Y; Feng Y; Zhang Y; Wu Z
    Clin Rheumatol; 2023 May; 42(5):1327-1338. PubMed ID: 36609932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome.
    Lee KE; Kang JH; Yim YR; Kim JE; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Yoon KC; Lee JS; Lee SS
    Clin Exp Rheumatol; 2017; 35(2):234-240. PubMed ID: 27782867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren's syndrome.
    Kim JW; Ahn MH; Jung JY; Suh CH; Han JH; Kim HA
    Clin Exp Med; 2024 Jun; 24(1):133. PubMed ID: 38900301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the expression levels of serum transforming growth factor-β and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
    He J; Xu C; Zhu Y; Xu M; Chen Y; Guo L; Jing Z; Xu B; Wu S
    Clin Rheumatol; 2023 Dec; 42(12):3283-3288. PubMed ID: 37755549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.
    Carubbi F; Alunno A; Cipriani P; Di Benedetto P; Ruscitti P; Berardicurti O; Bartoloni E; Bistoni O; Caterbi S; Ciccia F; Triolo G; Gerli R; Giacomelli R
    Semin Arthritis Rheum; 2014 Dec; 44(3):314-24. PubMed ID: 24935529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
    Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
    Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of salivary inflammatory biomarkers with primary Sjögren's syndrome.
    Moreno-Quispe LA; Serrano J; Virto L; Sanz M; Ramírez L; Fernández-Castro M; Hernández G; López-Pintor RM
    J Oral Pathol Med; 2020 Oct; 49(9):940-947. PubMed ID: 32538490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In patients with primary Sjögren's syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells.
    Hinrichs AC; Kruize AA; Leavis HL; van Roon JAG
    Front Immunol; 2022; 13():1017157. PubMed ID: 36505431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
    Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
    J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.